| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-05 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.14 | 9e-05 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |